ArticleJournal of inflammation (London, England)2019

Inhibition of pSTAT1 by tofacitinib accounts for the early improvement of experimental chronic synovitis.

Sandra Pérez-Baos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.